QMS Medical Allied Services P/B Ratio
Current P/B Ratio
1.89
Moderate Valuation
Moderate - Reasonably valued relative to book value
QMS Medical Allied Services (QMSMEDI) P/B ratio is 1.89 (Moderate), book value per share ₹59.44 vs Healthcare average P/B of -0.3 — Moderate - Reasonably valued relative to book value. View QMSMEDI price range for the annual high/low range and current price position.
Current Valuation Metrics
P/B Ratio
1.89
Current Price
₹107.56
Book Value/Share
₹59.44
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹107 Cr
Share Capital
₹18 Cr
Reserves & Surplus
₹72 Cr
Outstanding Shares
18,000,000
Book Value per Share
₹59.44
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.3
Sector Median
0.6
Sector Rank
#11 of 50
Sector Percentile
22.0%
QMSMEDI P/B Ratio — Valuation Insights & Book Value Analysis
QMS Medical Allied Services price-to-book ratio interpretation, valuation status and historical context — current P/B 1.89 (Moderate). For live price, earnings yield and the full fundamental profile, see QMS Medical Allied Services screener.
- Trading at premium to sector average PB of -0.3
QMSMEDI vs Healthcare Peers — P/B Ratio Comparison
QMS Medical Allied Services P/B 1.89 vs Healthcare average -0.3, median 0.6 — range -16.4–1.11.
Sector Average
-0.3
Sector Median
0.6
Lowest P/B
-16.4
Highest P/B
1.11
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -16.4 | ₹20 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |